Effects of GDF5 overexpression on embryonic rat dopaminergic neurones in vitro and in vivo

Journal of Neural Transmission

Volumn 117, Issue 5, 2010, Pages 559-572

  O'Sullivan, David B ^a   Harrison, Patrick T ^a   Sullivan, Aideen M ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Dopaminergic neurone; Growth differentiation factor 5; Neurotrophic factor; Parkinson's disease; Rat; Transplantation

Indexed keywords

AMPHETAMINE; GROWTH DIFFERENTIATION FACTOR 5; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; EMBRYO; GENE OVEREXPRESSION; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; LOCOMOTION; MALE; MESENCEPHALON; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; CELL SURVIVAL; CELLS, CULTURED; DOPAMINE; DYSKINESIA, DRUG-INDUCED; GRAFT SURVIVAL; GROWTH DIFFERENTIATION FACTOR 5; LIPIDS; MALE; MOVEMENT DISORDERS; OXIDOPAMINE; PARKINSON DISEASE; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; SYMPATHOLYTICS; TRANSFECTION; TREATMENT OUTCOME;

EID: 77952243958     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-010-0392-9     Document Type: Article

References (64)

1. L Alberi P Sgado HH Simon 2004 Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons Dev Dis 131 3229 3236 1:CAS:528:DC%2BD2cXmtFKltrk%3D
2. C Apostolides E Sanford M Hong I Mendez 1993 Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells Exp Neurol 124 401 412 10.1006/exnr.1993.1214 (Pubitemid 24041791)
3. M Bauer BW Kristensen M Meyer T Gasser HR Widmer J Zimmer M Ueffing 2006 Toxic effects of lipid-mediated gene transfer in ventral mesencephalic explant cultures Basic Clin Pharmacol Toxicol 98 395 400 10.1111/j.1742-7843.2006.pto- 310.x 1:CAS:528:DC%2BD28Xks1Ojtr8%3D 16623864
4. A Bjorklund 2005 Cell therapy for Parkinson's disease: problems and prospects Novartis Found Symp 265 174 186 10.1002/0470091452.ch14 16050257
5. A Bjorklund D Kirik C Rosenblad B Georgievska C Lundberg RJ Mandel 2000 Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model Brain Res 886 82 98 10.1016/S0006-8993(00)02915-2 1:CAS:528:DC%2BD3cXovFGktLs%3D 11119690
6. A Bjorklund SB Dunnett P Brundin AJ Stoessl CR Freed RE Breeze M Levivier M Peschanski L Studer R Barker 2003 Neural transplantation for the treatment of Parkinson's disease Lancet Neurol 2 437 445 10.1016/S1474-4422(03)00442-3 12849125 (Pubitemid 36793939)
7. P Brundin P Hagell 2001 The neurobiology of cell transplantation in Parkinson's disease Clin Neurosci Res 1 507 520 10.1016/S1566-2772(01)00028-7 1:CAS:528:DC%2BD38Xltlygsw%3D%3D (Pubitemid 33665568)
8. P Brundin J Karlsson M Emgard GS Schierle O Hansson A Petersen RF Castilho 2000 Improving the survival of grafted dopaminergic neurons: a review over current approaches Cell Transpl 9 179 195 1:STN:280:DC%2BD3czosVOmsg%3D%3D (Pubitemid 30252685)
9. DL Choi-Lundberg MC Bohn 1995 Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat Brain Res Dev Brain Res 85 80 88 10.1016/0165-3806(94)00197-8 1:CAS:528:DyaK2MXkvFWltbk%3D 7781171
10. KB Clayton AM Sullivan 2007 Differential effects of GDF5 on the medial and lateral rat ventral mesencephalon Neurosci Lett 427 132 137 10.1016/j.neulet.2007.09.025 1:CAS:528:DC%2BD2sXht1Kjsb3I 17935884 (Pubitemid 47633800)
11. T Deierborg D Soulet L Roybon V Hall P Brundin 2008 Emerging restorative treatments for Parkinson's disease Prog Neurobiol 85 407 432 10.1016/j.pneurobio.2008.05.001 1:CAS:528:DC%2BD1cXps1Gmsrk%3D 18586376
12. SB Dunnett A Bjorklund O Lindvall 2001 Cell therapy in Parkinson's disease-stop or go? Nat Rev Neurosci 2 365 369 10.1038/35072572 1:CAS:528:DC%2BD3MXjs12rtrs%3D 11331920 (Pubitemid 33680578)
13. C Ericson B Georgievska C Lundberg 2005 Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease Eur J Neurosci 22 2755 2764 10.1111/j.1460-9568.2005.04503.x 16324109 (Pubitemid 41811272)
14. CR Freed PE Greene RE Breeze WY Tsai W DuMouchel R Kao S Dillon H Winfield S Culver JQ Trojanowski D Eidelberg S Fahn 2001 Transplantation of embryonic dopamine neurons for severe Parkinson's disease New Engl J Med 344 710 719 10.1056/NEJM200103083441002 1:STN:280:DC%2BD3M7ltFCisQ%3D%3D 11236774 (Pubitemid 32204988)
15. SS Gill NK Patel GR Hotton K O'Sullivan R McCarter M Bunnage DJ Brooks CN Svendsen P Heywood 2003 Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease Nat Med 9 589 595 10.1038/nm850 1:CAS:528:DC%2BD3sXjtlamtLw%3D 12669033 (Pubitemid 36597106)
16. P Hagell P Brundin 2001 Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease J Neuropathol Exp Neurol 60 741 752 1:STN:280:DC%2BD3MvktFelug%3D%3D 11487048
17. P Hagell MA Cenci 2005 Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective Brain Res Bull 68 4 15 10.1016/j.brainresbull.2004.10.013 1:CAS:528:DC%2BD2MXht1OlsLvK 16324999 (Pubitemid 41698871)
18. BJ Hoffer A Hoffman K Bowenkamp P Huettl J Hudson D Martin LF Lin GA Gerhardt 1994 Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo Neurosci Lett 182 107 111 10.1016/0304-3940(94)90218-6 1:CAS:528:DyaK2MXislKlu7c%3D 7891873 (Pubitemid 24362034)
19. G Hotten H Neidhardt B Jacobowsky J Pohl 1994 Cloning and expression of recombinant human growth/differentiation factor 5 Biochem Biophys Res Commun 204 646 652 10.1006/bbrc.1994.2508 1:STN:280:DyaK2M%2FntFektw%3D%3D 7980526
20. JG Hou LF Lin C Mytilineou 1996 Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium J Neurochem 66 74 82 1:CAS:528:DyaK2MXhtVSns7rL 8522992
21. Howard CV, Reed MG (1998) Unbiased stereology. Bios Scientific Publishers, Oxford, UK
22. FM Hurley DJ Costello AM Sullivan 2004 Neuroprotective effects of delayed administration of growth/differentiation factor-5 in the partial lesion model of Parkinson's disease Exp Neurol 185 281 289 10.1016/j.expneurol.2003.10.003 1:CAS:528:DC%2BD2cXltVGjsQ%3D%3D 14736509 (Pubitemid 38084854)
23. CM Kearns DM Gash 1995 GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo Brain Res 672 104 111 10.1016/0006-8993(94)01366-P 1:CAS:528:DyaK2MXjs1Ckur0%3D 7749731
24. JH Kordower 2003 In vivo gene delivery of glial cell line-derived neurotrophic factor for Parkinson's disease Ann Neurol 53 S120 S132 10.1002/ana.10485 1:CAS:528:DC%2BD3sXjtFGitb0%3D 12666104 (Pubitemid 36368568)
25. JH Kordower Y Chu RA Hauser TB Freeman C Olanow 2008 Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease Nat Med 14 504 506 10.1038/nm1747 1:CAS:528:DC%2BD1cXlsFCmsrg%3D 18391962 (Pubitemid 351655212)
26. JH Kordower Y Chu RA Hauser CW Olanow TB Freeman 2008 Transplanted dopaminergic neurons develop PD pathologic changes: a second case report Mov Disord 23 2303 2306 10.1002/mds.22369 19006193
27. K Krieglstein C Suter-Crazzolara WH Fischer K Unsicker 1995 TGF-β superfamily members promote the survival of midbrain dopaminergic neurones and protect them against MPP+ toxicity EMBO J 14 736 742 1:CAS:528: DyaK2MXktF2ms7g%3D 7882977
28. K Krieglstein C Suter-Crazzolara G Hötten J Pohl K Unsicker 1995 Trophic and protective effects of growth/differentiation factor 5, a member of the transforming growth factor-β superfamily, on midbrain dopaminergic neurones J Neurosci Res 42 724 732 10.1002/jnr.490420516 1:CAS:528: DyaK2MXpvVWltbw%3D 8600306
29. AE Lang S Gill NK Patel A Lozano JG Nutt R Penn DJ Brooks G Hotton E Moro P Heywood MA Brodsky K Burchiel P Kelly A Dalvi B Scott M Stacy D Turner VG Wooten WJ Elias ER Laws V Dhawan AJ Stoessl J Matcham RJ Coffey M Traub 2006 Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease Ann Neurol 59 459 466 10.1002/ana.20737 1:CAS:528:DC%2BD28XjtV2lsbY%3D 16429411 (Pubitemid 43358066)
30. JY Li E Englund JL Holton D Soulet P Hagell AJ Lees T Lashley NP Quinn S Rehncrona A Björklund H Widner T Revesz O Lindvall P Brundin 2008 Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation Nat Med 14 501 503 10.1038/nm1746 1:CAS:528:DC%2BD1cXlsFCmsrs%3D 18391963 (Pubitemid 351655211)
31. LF Lin DH Doherty JD Lile S Bektesh F Collins 1993 GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons Science 260 1130 1132 10.1126/science.8493557 1:CAS:528:DyaK2cXks1Gguw%3D%3D 8493557
32. O Lindvall P Hagell 2000 Clinical observations after neural transplantation in Parkinson's disease Prog Brain Res 127 299 320 10.1016/S0079-6123(00)27014-3 1:STN:280:DC%2BD3M7gsFKrtQ%3D%3D 11142032 (Pubitemid 35461264)
33. TM Mayhew 1992 A review of recent advances in stereology for quantifying neural structure J Neurocytol 21 313 328 10.1007/BF01191700 1:STN:280: DyaK38zgtVeltg%3D%3D 1607876
34. PF Morrison RR Lonser EH Oldfield 2007 Convective delivery of glial cell line-derived neurotrophic factor in the human putamen J Neurosurg 107 74 83 10.3171/JNS-07/07/0074 17639877 (Pubitemid 47026475)
35. N Nakao EM Frodl W-M Duan H Widner P Brundin 1994 Lazaroids improve the survival of grafted rat embryonic dopamine neurons Proc Natl Acad Sci USA 91 12408 12412 10.1073/pnas.91.26.12408 1:CAS:528:DyaK2MXivVCrs7Y%3D 7809050
36. JG Nutt KJ Burchiel CL Comella J Jankovic AE Lang ER Laws Jr AM Lozano RD Penn RK Simpson Jr M Stacy GF Wooten 2003 Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD Neurology 60 69 73 1:CAS:528:DC%2BD38Xps1aiur8%3D 12525720
37. GW O'Keeffe P Dockery AM Sullivan 2004 Effects of growth/differentiation factor-5 on the survival and morphology of embryonic rat midbrain dopaminergic neurones in vitro J Neurocytol 33 479 488 10.1007/s11068-004-0511-y 15906156 (Pubitemid 40768572)
38. GW O'Keeffe M Hanke J Pohl AM Sullivan 2004 Expression of the dopaminergic neurotrophin growth/differentiation factor-5 in the developing and adult rat brain Dev Brain Res 151 199 202 10.1016/j.devbrainres.2004.04.004 (Pubitemid 38887747)
39. MJ O'Neill MJ Messenger V Lakics TK Murray EH Karran PG Szekeres ES Nisenbaum KM Merchant 2007 Neuroreplacement, growth factor, and small molecule neurotrophic approaches for treating Parkinson's disease Int Rev Neurobiol 77 179 217 10.1016/S0074-7742(06)77006-4 17178475
40. EC Ohki ML Tilkins VC Ciccarone PJ Price 2001 Improving the transfection efficiency of post-mitotic neurons J Neurosci Methods 112 95 99 10.1016/S0165-0270(01)00441-1 1:STN:280:DC%2BD3MnntFKgtg%3D%3D 11716945 (Pubitemid 33051112)
41. CW Olanow CG Goetz JH Kordower AJ Stoessl V Sossi MF Brin KM Shannon GM Nauert DP Perl J Godbold TB Freeman 2003 A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease Ann Neurol 54 403 414 10.1002/ana.10720 12953276 (Pubitemid 37072046)
42. NK Patel M Bunnage P Plaha CN Svendsen P Heywood SS Gill 2005 Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study Ann Neurol 57 298 302 10.1002/ana.20374 1:CAS:528:DC%2BD2MXhs1Citr8%3D 15668979 (Pubitemid 40179870)
43. Paxinos G, Watson C (1988) The rat brain in stereotaxic coordinates, 4th edn. Academic Press, San Diego
44. P Piccini N Pavese P Hagell J Reimar A Bjorklund WH Oertel NP Quinn DJ Brooks O Lindvall 2005 Factors affecting the clinical outcome after neural transplantation in Parkinson's disease Brain 128 2977 2986 10.1093/brain/awh649 16246865 (Pubitemid 41746650)
45. C Rosenblad A Martinez-Serrano A Bjorklund 1996 Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts Neuroscience 75 979 985 10.1016/0306-4522(96) 00343-0 1:CAS:528:DyaK28Xnt1Sksro%3D 8938733 (Pubitemid 26377085)
46. H Sauer C Rosenblad A Björklund 1995 Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion Proc Natl Acad Sci USA 92 8935 8939 10.1073/pnas.92.19.8935 1:CAS:528:DyaK2MXotVGqtrY%3D 7568047
47. M Sayles M Jain RA Barker 2004 The cellular repair of the brain in Parkinson's disease-past, present and future Transpl Immunol 12 321 342 10.1016/j.trim.2003.12.012 1:CAS:528:DC%2BD2cXkt1Sntrs%3D 15157925 (Pubitemid 38639727)
48. TB Sherer BK Fiske CN Svendsen AE Lang JW Langston 2006 Crossroads in GDNF therapy for Parkinson's disease Mov Disord 21 136 241 10.1002/mds.20861 16470786
49. SR Sinclair CN Svendsen EM Torres D Martin JW Fawcett SB Dunnett 1996 GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts Neuroreport 7 2547 2552 10.1097/00001756-199611040-00029 1:CAS:528:DyaK2sXhslWmtbk%3D 8981421
50. JT Slevin GA Gerhardt CD Smith DM Gash R Kryscio B Young 2005 Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor J Neurosurg 102 216 222 10.3171/jns.2005.102.2.0216 1:CAS:528: DC%2BD2MXhslygs7s%3D 15739547
51. CE Sortwell 2003 Strategies for the augmentation of grafted dopamine neuron survival Front Biosci 8 S522 S532 10.2741/1096 1:CAS:528: DC%2BD3sXjvVels78%3D 12700087
52. AM Sullivan J Opacka-Juffry G Hötten J Pohl SB Blunt 1997 Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurones in a rat model of Parkinson's disease Neurosci Lett 233 73 76 10.1016/S0304- 3940(97)00623-X 1:CAS:528:DyaK2sXmtlCiu7Y%3D 9350835 (Pubitemid 27418167)
53. AM Sullivan J Opacka-Juffry SB Blunt 1998 Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo Eur J Neurosci 10 57 63 10.1046/j.1460-9568.1998.00016.x 1:STN:280:DyaK1cvisVSgtw%3D%3D 9753113 (Pubitemid 28325426)
54. AM Sullivan J Pohl SB Blunt 1998 Growth/differentiation factor 5 and glial cell line-derived neurotrophic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson's disease Eur J Neurosci 10 3681 3688 10.1046/j.1460-9568.1998.00378.x 1:STN:280:DyaK1M%2Fpt1GjtA%3D%3D 9875347 (Pubitemid 29073925)
55. AM Sullivan J Opacka-Juffry J Pohl SB Blunt 1999 Neuroprotective protective effects of growth/differentiation factor 5 depend on the site of administration Brain Res 818 176 179 10.1016/S0006-8993(98)01275-X 1:CAS:528:DyaK1MXmtVGjsg%3D%3D 9914454 (Pubitemid 29227300)
56. SM Tatarewicz X Wei S Gupta D Masterman SJ Swanson MS Moxness 2007 Development of a maturing T-cell-mediated immune response in patients with idiopathic Parkinson's disease receiving r-metHuGDNF via continuous intraputaminal infusion J Clin Immunol 27 620 627 10.1007/s10875-007-9117-8 17629719
57. A Tomac E Lindqvist LF Lin SO Ogren D Young BJ Hoffer L Olson 1995 Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo Nature 373 335 339 10.1038/373335a0 1:CAS:528:DyaK2MXjtlygtbc%3D 7830766
58. EM Torres UM Weyrauch R Sutcliffe SB Dunnett 2008 A rat embryo staging scale for the generation of donor tissue for neural transplantation Cell Transpl 17 535 542 10.3727/096368908785096006 1:STN:280:DC%2BD1crjsFyitg%3D%3D
59. A Toulouse AM Sullivan 2008 Progress in Parkinson's disease-where do we stand? Prog Neurobiol 85 376 392 10.1016/j.pneurobio.2008.05.003 18582530
60. Y Wang LT Tien PA Lapchak BJ Hoffer 1996 GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats Cell Tissue Res 286 225 233 10.1007/s004410050691 1:CAS:528: DyaK28Xnt1ygsb8%3D 8854891 (Pubitemid 26383669)
61. P Washbourne AK McAllister 2002 Techniques for gene transfer into neurons Curr Opin Neurobiol 12 566 573 10.1016/S0959-4388(02)00365-3 1:CAS:528:DC%2BD38XnsVansrw%3D 12367637 (Pubitemid 35284093)
62. TK Wood KW McDermott AM Sullivan 2005 Differential effects of growth/differentiation factor 5 and glial cell line-derived neurotrophic factor on dopaminergic neurons and astroglia in cultures of embryonic rat midbrain J Neurosci Res 80 759 766 10.1002/jnr.20507 1:CAS:528:DC%2BD2MXkvF2nurk%3D 15880784 (Pubitemid 40961287)
63. L-Y Yu U Arumade 2008 Survival assay of transiently transfected dopaminergic neurons J Neurosci Methods 169 8 15 10.1016/j.jneumeth.2007.11.018 1:CAS:528:DC%2BD1cXislGks70%3D 18191457
64. AD Zurn HR Widmer P Aebischer 2001 Sustained delivery of GDNF: towards a treatment for Parkinson's disease Brain Res Brain Res Rev 36 222 229 10.1016/S0165-0173(01)00098-4 1:CAS:528:DC%2BD3MXnvFCkt7o%3D 11690619 (Pubitemid 33020752)